Literature DB >> 2685096

Hyperprolactinemia: neuroendocrine and diagnostic aspects.

F Camanni1, E Ciccarelli, E Ghigo, E E Müller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2685096     DOI： 10.1007/BF03350030

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  108 in total

1.  Sustained elevation of serum prolactin by metoclopramide: a clinical model of idiopathic hyperprolactinemia.

Authors:  D L Healy; H G Burger
Journal:  J Clin Endocrinol Metab       Date:  1978-05       Impact factor: 5.958

2.  Prolactin turnover in rat adenohypophyses in vivo: its evaluation as a method for estimating secretion rates.

Authors:  K C Swearingen; C S Nicoll
Journal:  J Endocrinol       Date:  1972-04       Impact factor: 4.286

3.  Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma.

Authors:  K Seki; K Kato; K Shima
Journal:  J Clin Endocrinol Metab       Date:  1986-04       Impact factor: 5.958

4.  Basal and TRH stimulated serum levels of TSH in patients with hyperprolactinaemia and in subjects on oestrogen treatment.

Authors:  E M Erfurth; P Hedner; A Nilsson
Journal:  Acta Endocrinol (Copenh)       Date:  1983-02

5.  Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients.

Authors:  S Bansal; L A Lee; P D Woolf
Journal:  Am J Med       Date:  1981-12       Impact factor: 4.965

6.  Influence of prolactin on dopaminergic neuronal systems in the hypothalamus.

Authors:  K E Moore; K T Demarest; C A Johnston
Journal:  Fed Proc       Date:  1980-09

7.  Abnormal regulation of prolactin secretion after successful surgery for prolactin-secreting pituitary tumours.

Authors:  J A Schlechte; B M Sherman
Journal:  Clin Endocrinol (Oxf)       Date:  1981-08       Impact factor: 3.478

8.  Functional characterization of hypothalamic hyperprolactinemia.

Authors:  C Ferrari; P Rampini; R Benco; R Caldara; C Scarduelli; P G Crosignani
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

9.  A radioimmunoassay for human prolactin.

Authors:  P Hwang; H Guyda; H Friesen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

10.  Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa.

Authors:  M E Molitch; R H Goodman; K D Post; B J Biller; A C Moses; L W King; Z T Feldman; S Reichlin
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958
View more
  3 in total

Review 1.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04

2.  Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients.

Authors:  S Grottoli; P Razzore; E Arvat; S E Oleandri; R Rossetto; E Ciccarelli; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1997-11       Impact factor: 4.256

Review 3.  Diagnosis and drug therapy of prolactinoma.

Authors:  E Ciccarelli; F Camanni
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.